Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Marina M. Sergeeva"'
Autor:
Natalia Yu. Samaneva, Liubov Yu Vladimirova, Anna E. Storozhakova, Elena A. Kalabanova, Sergey N. Kabanov, Anna V. Tishina, Yakha S. Gaysultanova, Maria A. Teplyakova, Aza A. Lyanova, Natalia A. Abramova, Ludmila A. Ryadinskaya, Irina A. Udalenkova, Natalia M. Tikhanovskaya, Irina L. Popova, Marina M. Sergeeva, Larisa N. Vashchenko
Publikováno v:
Journal of Clinical Oncology. 40:e13072-e13072
e13072 Background: Breast cancer (BC) is the most common cancer in women worldwide. The purpose of the study was to analyze immediate and long-term results of treatment in patients with locally advanced primarily inoperable HER2-negative breast cance
Autor:
Aza A. Lyanova, Liubov Yu Vladimirova, Elena P. Ulianova, Natalia A. Abramova, Irina L. Popova, Anna E. Storozhakova, Natalia M. Tikhanovskaya, Ludmila A. Ryadinskaya, Maria A. Teplyakova, Sergey N. Kabanov, Elena A. Kalabanova, Irina A. Udalenkova, Marina A. Engibaryan, Irina V. Pustovaya, Maria A. Cherkes, Marina M. Sergeeva
Publikováno v:
Journal of Clinical Oncology. 40:e18072-e18072
e18072 Background: Clinical course and aggressiveness of a tumor, as well as the subtle mechanisms of its pathogenesis are related to vascularization, which in turn is determined by the ability of transformed cells to synthesize a wide range of biolo
Autor:
Maria A. Teplyakova, Liubov Yu Vladimirova, Irina L. Popova, Aza A. Lyanova, Natalia A. Abramova, Anna E. Storozhakova, Ludmila A. Ryadinskaya, Natalia M. Tikhanovskaya, Irina A. Udalenkova, Elena A. Kalabanova, Sergey N. Kabanov, Aleksandr B. Sagakyants, Elena Yu Zlatnik, Oksana G. Shulgina, Ekaterina I. Zolotareva, Elena P. Ulianova, Takhmina M. Kecheryukova, Marina M. Sergeeva, Yuriy N. Lazutin, Dmitry A. Kharagezov
Publikováno v:
Journal of Clinical Oncology. 40:e21068-e21068
e21068 Background: Lung cancer (LC) is one of the most commonly diagnosed cancers and leading causes of cancer death worldwide. A limited clinical benefit of checkpoint inhibitor therapy (CIT) remains an important issue. Various units of the immune s
Autor:
Liubov Yu Vladimirova, Aleksandr B. Sagakyants, Anna V. Tishina, Oksana G. Shulgina, Anna E. Storozhakova, Ekaterina I. Zolotareva, Inna A. Novikova, Elena A. Kalabanova, Sergey N. Kabanov, Natalia Yu. Samaneva, Maria A. Teplyakova, Natalia M. Tikhanovskaya, Natalia A. Abramova, Irina A. Udalenkova, Ludmila A. Ryadinskaya, Irina L. Popova, Marina M. Sergeeva, Oleg I. Kit, Elena A. Dzhenkova, Evgeniy N. Kolesnikov
Publikováno v:
Journal of Clinical Oncology. 40:e15545-e15545
e15545 Background: For many years, colorectal cancer has been among the most frequently diagnosed cancers and one of the leading causes of cancer death. The effect of monoclonal antibodies on the immunological status remains relevant, since chemother
Publikováno v:
Вестник Московского государственного областного университета. Серия: Психологические науки, Iss 4, Pp 117-128 (2018)
The article describes the features of older adolescents’psychological adaptation in the conditions of separate and mixed education. To identify the level of students’psychological adaptation the method of (personality questionnaire) of socio-psyc
Autor:
Irina L. Popova, Faina V. Alieva, Aza A. Agieva, Oleg N. Burov, Yaroslav S. Enin, Natalia M. Tikhanovskaya, Marina M. Sergeeva, Valeriya S Myagkova, Liubov Yu Vladimirova, Ludmila A. Ryadinskaya, Natalia A. Abramova, Maria A. Teplyakova, Elena Yu. Zlatnik, Kristina A. Novoselova
Publikováno v:
Journal of Clinical Oncology. 39:e15063-e15063
e15063 Background: The study of the possible antitumor activity of secondary plant metabolites either in the form of individual agents or in combination with clinically used drugs is considered as a promising direction in the therapy of malignant tum
Autor:
A.S. Ratieva, Natalia M. Tikhanovskaya, Aza A. Agieva, Valeriya S Myagkova, Ekaterina P. Omelchuk, Irina L. Popova, Ludmila A. Ryadinskaya, Natalya N. Timoshkina, Faina V. Alieva, Dmitry Yu. Gvaldin, Liubov Yu Vladimirova, Marina M. Sergeeva, Kristina A. Novoselova, Larisa N. Vashchenko, Natalia A. Abramova, Maria A. Teplyakova
Publikováno v:
Journal of Clinical Oncology. 39:12005-12005
12005 Background: Numerous pharmacogenetic studies have led to the identification of genetic polymorphisms associated not only with the development of cardiovascular disease, but also increase the risk of complications due to the use of anthracycline
Autor:
Irina V. Neskubina, Maria A. Teplyakova, Marina A. Engibaryan, Aza A. Lyanova, Valeriya S Myagkova, Yuriy A. Fomenko, Natalia A. Abramova, Oleg I. Kit, Elena M. Frantsiyants, Irina L. Popova, Marina M. Sergeeva, Ludmila A. Ryadinskaya, Natalia M. Tikhanovskaya, Kristina A. Novoselova, Elena V. Shalashnaya, Liubov Yu Vladimirova
Publikováno v:
Journal of Clinical Oncology. 38:e18563-e18563
e18563 Background: Cetuximab is a monoclonal antibody directed against the EGFR receptor, able to block the EGFR signaling pathway and also indirectly affect the secretion of some growth factors. The search for biomarkers responsible for cetuximab re
Autor:
Liubov Yu Vladimirova, Valeria A. Bandovkina, Natalia D. Cheryarina, Elena A. Sheiko, Oleg I. Kit, Elena M. Frantsiyants, Aleksandr E. Lisutin, Anna E. Storozhakova, Evgeniya M. Nepomnyashchaya, Marina M. Sergeeva, Natalia Yu. Samaneva
Publikováno v:
Web of Science
e12551 Background: Breast cancer (BC) is still one of the main causes of death in women due to the tumor recurrence and/or resistance to anticancer therapy. The criteria to assess the risk of tumor progression in breast cancer after 2 chemotherapy cy
Autor:
Anna E. Storozhakova, Kristina A. Novoselova, Irina A. Zhuzhelenko, Irina L. Popova, Aza A. Lyanova, Georgy Salamov, Sergey N. Kabanov, Marina M. Sergeeva, Irina Kornilova, Elena A. Kalabanova, Nataliya Samaneva, Natalya Mikhailovna Tikhanovskaya, Jana V. Svetickaja, Ludmila A. Ryadinskaya, Natalya A Abramova, T A Snezhko, Liubov Yu Vladimirova
Publikováno v:
Journal of Clinical Oncology. 36:e16211-e16211
e16211Background: The purpose of the study was to analyze the survival of patients with pancreatic cancer II-IV stages depending on the regimen used in the first line. Methods: The data of adults t...